newsfilter
← Latest News
GlobeNewswire·

KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare